Study Summary
This trial will test whether a new method of transcranial magnetic stimulation can specifically help people with OCD who experience contamination/washing symptoms.
- Obsessive-Compulsive Disorder
Video Summary
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 6 weeks
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
iTBS
1 of 3
cTBS
1 of 3
sham
1 of 3
Experimental Treatment
Non-Treatment Group
50 Total Participants · 3 Treatment Groups
Primary Treatment: cTBS · Has Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Tennessee | 50.0% |
| Texas | 50.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| McLean Hospital | 100.0% |
Frequently Asked Questions
What is the most populous cohort of individuals participating in this research?
"Affirmative. According to records on clinicaltrials.gov, this medical experiment – which was initialy posted on July 1st 2022 – is actively seeking out potential participants. There are 50 spots to fill at one trial site." - Anonymous Online Contributor
Are any individuals aged 20 or over permitted to join this experiment?
"In order to be considered for this medical study, the applicant must fall between 18 and 55 years old as stipulated in the eligibility requirements." - Anonymous Online Contributor
Are there any open slots remaining for this trial?
"Affirmative. Clinicaltrials.gov data shows that this clinical trial is still searching for participants as of November 14th, 2022; the study was initially published on July 1st, 2022 and requires 50 enrollees at a single site." - Anonymous Online Contributor
Can I join the research project?
"This trial seeks 50 individuals aged 18 to 55, who struggle with obsessive-compulsive disorder. Crucially, they must have CONTAM as their foremost symptom dimension (highest score on the Dimensional Yale-Brown Obsessive Compulsive Scale), not initiate a new course of exposure and response prevention therapy within 8 weeks of enrollment (continuing ERP will be allowed if begun more than 8 weeks before enrolment) and achieve at least an 8/20 on Dimension 4 of the DYBOCS." - Anonymous Online Contributor